期刊文献+

国产罗格列酮治疗2型糖尿病疗效观察 被引量:1

下载PDF
导出
摘要 目的 :观察国产罗格列酮治疗 2型糖尿病的效果。方法 :采用随机、双盲平行对照试验 ,将 2型糖尿病患者 4 2例 ,分为观察组和对照组各 2 1例。观察组每天早餐前 15 min口服国产罗格列酮片 4 m g,连续服 12周。对照组口服马来酸罗格列酮片 ,药物剂量及服用方法均与观察组相同。服药前后检测空腹血糖 (FBG)及餐后血糖 (PBG)、血清胰岛素、Hb A1 c、血脂参数。结果 :治疗后两组 FBG及 PBG、Hb A1 c、空腹胰岛素、HOMA- IR均较治疗前明显下降 (P <0 .0 1) ,但两组间比较除治疗后 2周的 PBG外差异均无统计学意义 (P >0 .0 5 )。观察组和对照组有效率比较差异亦无统计学意义 (P >0 .0 5 )。治疗后两组 HDL -ch均较治疗前明显下降 (P <0 .0 5 ) ,但绝对值仍在正常范围内。结论 :国产罗格列酮治疗 2型糖尿病的疗效与马来酸罗格列酮相似 。
出处 《广西医科大学学报》 CAS 2002年第6期811-813,共3页 Journal of Guangxi Medical University
  • 相关文献

参考文献9

  • 1钱荣立.关于糖尿病的新诊断标准与分型[J].中国糖尿病杂志,2000,8(1):5-6. 被引量:2312
  • 2Dana SL,Hoener PA,Bilakovics JM,et al. Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat. Metabolism, 2001,50: 963-971.
  • 3Rieussrt J,Chambrier C,Bouzakri K,et al. The expression of the p85alpha subunit of phosphatidylinositol 3-kinase is induced by activation of the peroxisome proliferator-activatedreceptor gamma in human adipocytes. Diabetologia,2001,44: 544-554.
  • 4Raskin P,Rendrll M,Riddle MC,et al. A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes. Diabetes Care, 2001,24:1226-1232.
  • 5Wolffenbuttel BH, Sels JP, Huijberts MS. Rosiglitazone.Expert Opin Pharmacother, 2001,2: 467-478.
  • 6Fonseca V, Rosenstock J, Patwardhan R, et al. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus:, a randomized controlled trial. JAMA,2000,283:1695-1702.
  • 7Lebovitz HE,Dole JF,Patwardhan R,et al. Rosiglitazone monotherapy is effective in patients with type 2 diabetes. J Clin Endocrinol Metab, 2001,86: 280-288.
  • 8Gegick CG,Altheimer MD. Comparison of effects of thiazolidinediones on cardiovascular risk factors: observations from aclinical practice. Endocr Pract, 2001,7:162-169.
  • 9Phillips LS,Grunberger G,Miller E,et al. Once-and twicedaily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes. Diabetes Care, 2001, 24:308-315.

共引文献2311

同被引文献8

  • 1UK Prospective Diabetes Study(UKPDS)Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33)[J].Lancet,1988,352:837-853.
  • 2Grundy SM,Benjamin CI,Burke GL,et al.Diabetes and cardiovascular disease[J].Circulation,1999,100:1134.
  • 3Raskin P,Rappaport EB,Cole ST,et al.Rosiglitazone shortterm monotherapy lowers fasting and post-prandial slncose in patiens with type Ⅱ diabetes[J].Diabetologia,2000,43(3):278-284.
  • 4Lefebvre AM,Peinado-Onsurbe J,Leitersdorf I,et al.Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates[J].Arterioscler Thromb Vase Biol,1997,17(9):1756-1764.
  • 5Parulkar AA,Pendergrass ML,Granda-Ayala R,et al.Nonhypoglycemic effects of thiazolidinediones[J].Ann Intern Med,2001,134(1):61-71.
  • 6Chen Z,Ishibashi S,Perrey S,et al,Troglitazone inhibits atherosclerosis in apolipopmtein E-knockout mice:pleiotropic effects on CD36 expression and HDI[J].Arterioscler Thromb Vasc Biol,2001,21(3):372-7.
  • 7Gouni-Berthold I,Berthold HK,Weber AA,et al.Troglitazone and msiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth[J].Exp Clin Endocrinol Diabetes,2001,109(4):203-209.
  • 8Bakris G,Weston W,Rappaport E,et al.Rosiglitazone reduces urinary albumin excretion in type Ⅱ diabetes[J].J Hum Hypertens,2003,17(1):7-12.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部